Wave Life Sciences Reports First Quarter 2023 Financial Results and Provides Business Update
03.05.2023 - Emerging leader in RNA medicines with multi-modal discovery and development platform and first-in-class RNA editing programs Rapidly advancing toward 2023 CTA submissions and first-in-human study for WVE-006, the industry’s first RNA editing ...